Revenue: The sum of all revenue fields included for a company's operating activities.
C4 Therapeutics, Inc. (CCCC) had Revenue of $6.46M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$6.46M |
$-26.02M |
|
-- |
|
$6.46M |
|
$34.96M |
|
$-28.50M |
|
$2.48M |
|
$-26.02M |
|
$-26.02M |
|
$-26.02M |
|
$-26.02M |
|
$-26.02M |
|
$-26.02M |
|
$-28.50M |
|
$-28.47M |
|
71.01M |
|
71.01M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$224.73M |
|
$5.54M |
|
$71.80M |
|
$296.53M |
|
$44.46M |
|
-- |
|
$78.01M |
|
$122.46M |
|
$174.06M |
|
$174.06M |
|
$174.06M |
|
71.01M |
|
| Cash Flow Statement Financials | |
$-45.34M |
|
$68.05M |
|
$-0.05M |
|
$58.94M |
|
$81.60M |
|
$22.66M |
|
$10.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-440.99% |
|
-440.99% |
|
-- |
|
-402.60% |
|
-402.60% |
|
$-45.53M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
2.99 |
|
30.05 |
|
-14.95% |
|
-14.95% |
|
-8.77% |
|
-14.95% |
|
$2.45 |
|
$-0.64 |
|
$-0.64 |
|